Veradigm Announces Strategic Investment in Holmusk
10 January 2023 - 7:53AM
Business Wire
This collaboration fuels the expansion of a
leading source of real-world clinical behavioral health data
Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare
Solutions, Inc., announced today an investment in Holmusk, a global
behavioral health real-world evidence and data analytics company,
as part of Holmusk’s $45 million series B financing round. The
round was led by Veradigm, with participation from current
investors including Heritas Capital, Health Catalyst Capital,
Novartis (dRx Capital), and Northwell Holdings, the venture
investment arm of Northwell Health, as well as other previous
investors.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230109005849/en/
Holmusk will leverage this investment to continue its rapid
expansion of its flagship offering, the NeuroBlu Database—a leading
source of real-world clinical data for the behavioral health
industry.
Now that the financing has been completed, Veradigm and Holmusk
intend to enter into a data partnership to bring cohorts of
behavioral health and related de-identified patient data from
Veradigm to the NeuroBlu Database, significantly adding to
Holmusk’s real-world clinical data asset.
“Mental and behavioral health is a serious global health problem
that has only increased during and post the COVID-19 pandemic,”
said Rick Poulton, Veradigm Chief Executive Officer. “Holmusk has
proven expertise to create the evidence needed to improve mental
health. We are proud to equip the company with the resources needed
to advance this important work.”
“This investment will enable our team to continue its work in
curating and enhancing data as we plan to build the world’s largest
platform for behavioral health data,” said Nawal Roy, Holmusk
Founder and CEO. “We remain laser-focused on this mission because
we know that quality data leads to improved evidence, which leads
to better health outcomes.”
“We feel fortunate to form a partnership with Veradigm, a
company that shares our vision for the transformative power that
data can have in health care,” said Michael Weintraub, Chair of the
Holmusk Board. “Working collaboratively will help us to deepen our
investment in the behavioral health space and make a broader
impact.”
About Veradigm®
Veradigm is a healthcare technology company that drives value
through its unique combination of platforms, data, expertise,
connectivity, and scale. The Veradigm Network features a dynamic
community of solutions and partners providing advanced insights,
technology, and data-driven solutions, all working together to
transform healthcare insightfully. For more information on
Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn,
Facebook, Twitter, and YouTube.
About Holmusk
Holmusk is on a mission to harness real-world data to transform
both research and care for behavioral health. Combining the leading
behavioral health database with AI-powered analytics and digital
solutions designed to address the most pressing challenges in
behavioral health, Holmusk is advancing the frontier of evidence
generation and fueling innovation. Holmusk is headquartered in New
York and Singapore, with three additional offices around the world.
For more information, please visit www.holmusk.com.
© 2023 Veradigm Inc. and/or its affiliates. All Rights
Reserved.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding the beliefs, intentions or
goals of Veradigm and Holmusk. These forward-looking statements are
based on current beliefs and expectations, only speak as of the
date that they are made, and are subject to significant and
inherent risks and uncertainties. Such statements can be identified
by the use of words such as “future,” “anticipates,” “believes,”
“estimates,” “expects,” “intends,” “plans,” “predicts,” “will,”
“would,” “could,” “can,” “may,” and similar terms. Certain factors
that could cause the results described in this release to differ
materially from those described in the forward-looking statements
include, but are not limited to, the ability of Veradigm and
Holmusk to enter into a definitive agreement relating to the data
partnership described herein. Veradigm does not undertake to update
forward-looking statements to reflect changed assumptions, the
impact of circumstances or events that may arise after the date of
the forward-looking statements, or other changes in its business,
financial condition, or operating results over time.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230109005849/en/
Investors: Jenny Gelinas
312-506-1237 jenny.gelinas@veradigm.com
Media: Concetta Rasiarmos
312-447-2466 concetta.rasiarmos@veradigm.com
Kaitlin Jansen 704-995-2384 kaitlin.jansen@holmusk.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024